Peter Greenlee
President and Chief Executive Officer
Replay available
Aurinia Pharmaceuticals Inc (AUPH) Q3 2025 Earnings Call
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Q3 2025 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Joe Miller
Chief Financial Officer
Dr. Greg Keenan
Chief Medical Officer
Stacy Q
Analyst, TV Calendars
Olivia Breyer
Analyst, Cantor
Borey Raycroft
Analyst, Jefferies
Arthur He
Analyst, HC Wainwright
David Martin
Analyst, Bloomberg
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Aurinia Pharmaceuticals Inc.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:06.078 Good morning. Welcome to the Orinia Pharmaceuticals third quarter 2025 conference call. 00:00:06.078 -- 00:00:10.804 Please be advised that a Q&A session will follow Orinia's prepared remarks. 00:00:10.804 -- 00:00:14.589 I will now turn the call over to Peter Greenlee, President and Chief Executive Officer 00:00:14.589 -- 00:00:16.709 of Orinia. 00:00:16.972 -- 00:00:22.859 Thank you all for joining us to discuss Orinia's third quarter 2025 update. 00:00:22.859 -- 00:00:28.078 Joining me on the call today are Joe Miller, our Chief Financial Officer, and 00:00:28.078 -- 00:00:32.763 Dr. Greg Keenan, our Chief Medical Officer. 00:00:33.247 -- 00:00:38.295 Before we begin our discussion, I'd like to direct your attention to slide two, which 00:00:38.295 -- 00:00:43.220 contains important information regarding forward-looking statements. 00:00:43.604 -- 00:00:48.893 Additionally, we note that on November 2nd, ARINIA filed a complaint against 00:00:48.893 -- 00:00:55.178 Dr. George Tidmarsh arising from his statements about Bacillus borum, 00:00:55.178 -- 00:00:59.965 The complaint is pending in the United States District Court for the District of Maryland 00:00:59.965 -- 00:01:02.809 and is available online. 00:01:02.809 -- 00:01:08.197 If you have questions regarding the complaint, we refer you to the complaint itself as 00:01:08.197 -- 00:01:12.520 we will not be commenting further on this matter. 00:01:13.484 -- 00:01:19.253 On today's call, we will report third quarter 2025 financial results 00:01:19.253 -- 00:01:23.536 and provide an update on recent business progress. 00:01:23.933 -- 00:01:28.959 We're pleased to report that third quarter 2025 loop kind of sales experienced 00:01:28.959 -- 00:01:34.166 continued momentum followi...